Chemical formula: C₁₇H₁₈FN₃O₃ Molecular mass: 331.342 g/mol PubChem compound: 2764
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
ATC code | Group title | Classification |
---|---|---|
J01MA02 | Ciprofloxacin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones |
S01AE03 | S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones | |
S02AA15 | Ciprofloxacin | S Sensory organs → S02 Otologicals → S02A Antiinfectives → S02AA Antiinfectives |
S03AA07 | Ciprofloxacin | S Sensory organs → S03 Ophthalmological and otological preparations → S03A Antiinfectives → S03AA Antiinfectives |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Title | Information Source | Document Type | |
---|---|---|---|
CIPROFLOXACIN Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CIPRO Film-coated tablet / Oral suspension kit | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
CETRAXAL Ear drops | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CILOXAN Ointment | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
CILOXAN Eye drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
CILOXAN Ophthalmic solution | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
CIPROFLOXACIN Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Ciprofloxacin is an active ingredient of these brands:
United States (US)Albania (AL)
Australia (AU)Austria (AT)
Brazil (BR)
Canada (CA)Croatia (HR)Cyprus (CY)
Ecuador (EC)
Estonia (EE)
Finland (FI)
France (FR)Germany (DE)
Hong Kong (HK)
Ireland (IE)Israel (IL)Italy (IT)
Japan (JP)
Lithuania (LT)Malta (MT)
Mexico (MX)Netherlands (NL)
New Zealand (NZ)Nigeria (NG)
Poland (PL)
Romania (RO)
Singapore (SG)
South Africa (ZA)
Spain (ES)
Tunisia (TN)Turkey (TR)
United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.